What is Lux Health Tech Acquisition Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Lux Health Tech Acquisition's interest expense for the
three
months ended in Jun. 2022 was $ 0.00 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Jun. 2022 was $0.00 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Lux Health Tech Acquisition's Operating Income for the
three
months ended in Jun. 2022 was $ -0.47 Mil. Lux Health Tech Acquisition's Interest Expense for the
three
months ended in Jun. 2022 was $ 0.00 Mil.
Lux Health Tech Acquisition has no long-term debt (1).
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Lux Health Tech Acquisition Interest Expense Historical Data
The historical data trend for Lux Health Tech Acquisition's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lux Health Tech Acquisition Interest Expense Chart
|
Lux Health Tech Acquisition Annual Data
|
|
Trend |
Dec20 |
Dec21 |
| Interest Expense |
|
- |
- |
|
Lux Health Tech Acquisition Quarterly Data
|
|
Aug20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
| Interest Expense |
Get a 7-Day Free Trial
|
- |
- |
- |
- |
- |
Lux Health Tech Acquisition Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lux Health Tech Acquisition (NAS:LUXA) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Lux Health Tech Acquisition's Interest Expense for the
three
months ended in Jun. 2022 was $0.00 Mil. Its
Operating Income
for the
three
months ended in Jun. 2022 was $-0.47 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Jun. 2022 was $0.00 Mil.
Lux Health Tech Acquisition's Interest Coverage for the quarter that ended in Jun. 2022 is calculated as
| Lux Health Tech Acquisition had no long-term debt (1). |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description
Traded in Other Exchanges
N/A
Address
920 Broadway, 11th Floor, New York, NY, USA, 10010
Lux Health Tech Acquisition Corp is a blank check company.
Executives
| Frederic H Moll |
director |
C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086 |
| Joshua Defonzo |
director, officer: Chief Executive Officer |
1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070 |
| Peter Hebert |
director, 10 percent owner |
C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017 |
| J Robert Kerrey |
director |
NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036 |
| Josh Wolfe |
10 percent owner |
C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010 |
| Bijan Salehizadeh |
director |
C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005 |
| Segolene Scarborough |
officer: CFO and Treasurer |
C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010 |
| Lux Encore Sponsor, Lp |
10 percent owner |
C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010 |
| Lux Encore Holdings, Llc |
10 percent owner |
C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010 |
Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUXA has been successfully added to your